Approval · Notice of Compliance 17982 · 2016
BAR-MORPHINE SR: Notice of Compliance 17982
Issued April 12, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17982
- Date
- April 12, 2016
- Company
- Bard Pharmaceuticals (1990) IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Labelling assessment and licensing agreement between two companies
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BAR-MORPHINE SR | 02453800 | Cancelled Pre Market |
| BAR-MORPHINE SR | 02453827 | Cancelled Pre Market |
| BAR-MORPHINE SR | 02453843 | Cancelled Pre Market |
| BAR-MORPHINE SR | 02453851 | Cancelled Pre Market |
| BAR-MORPHINE SR | 02453878 | Cancelled Pre Market |
Medicinal ingredients
- MORPHINE SULFATE 15 MG per TAB
- MORPHINE SULFATE 30 MG per TAB
- MORPHINE SULFATE 60 MG per TAB
- MORPHINE SULFATE 100 MG per TAB
- MORPHINE SULFATE 200 MG per TAB